Dialogue's Clinical Decision Support Technology Earns CE Mark Approval
Company announces upcoming launch in Europe
MONTREAL, Nov. 8, 2019 /CNW Telbec/ - Canada's leading virtual care company, today announced it has achieved European Union Class 1 CE marking for its Clinical Decision Support Technology Medical Device. This recognition for its cutting-edge technology powered by Artificial Intelligence is the first step before a planned international expansion in Europe.
"This is a great step forward for Dialogue only made possible by the close collaboration of our cross-functional medical and technology teams. I am proud to be exporting our Canadian technology to improve the way quality care is delivered all over the world." - Cherif Habib, Co-founder and CEO, Dialogue
"The use of AI in healthcare supports medical professionals to better respond to patients' needs. As the only Canadian virtual care company to have developed and to use this technology, I am extremely hopeful for this innovation to continue improving access to care within our virtual clinic, but also in other environments such as emergency rooms around the world." - Dr. Julien Martel, Chief Medical Officer, Dialogue
Dialogue is a virtual platform offering integrated health care services for employers to keep their employees happy, healthy, and performing at their highest potential. A full range of health professionals (nurses, physicians and allied health practitioners) are available at the click of a button via mobile phone or computer to help employees optimize their work-life balance. To learn more, visit dialogue.co, follow us on Twitter or visit our Facebook and LinkedIn pages.
SOURCE Dialogue Technologies Inc.
Competitive Advantages of Edge Analytics
Key Tools of the IoT Security Trade